Marker Therapeutics Inc (MRKR)

[hanscott]

Man that presentation is chock full of incredibly good info! It answers at least partially some questions here about the future plans of the company.

This was particularly good to hear IMHO:

"We expect around that time to have our pre-IND meeting for our pivotal Phase 2 study, the seamless pivotal Phase 2 with a filing of the IND no later than the early third quarter. We do expect to have first patient in that seamless Phase 2 before year-end. We expect that to be about 27 multicenter trial that should be able to read out within 18 to 24 months of initiation" p. 7, paragraph 2.